1. Home
  2. TCX vs ENLV Comparison

TCX vs ENLV Comparison

Compare TCX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

N/A

Current Price

$13.20

Market Cap

167.0M

Sector

Technology

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.53

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCX
ENLV
Founded
1992
2005
Country
Canada
Israel
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
149.0M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
TCX
ENLV
Price
$13.20
$0.53
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
32.2K
339.6K
Earning Date
05-07-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$362,275,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.76
N/A
52 Week Low
$12.68
$0.52
52 Week High
$25.17
$2.10

Technical Indicators

Market Signals
Indicator
TCX
ENLV
Relative Strength Index (RSI) 41.97 25.70
Support Level $12.84 N/A
Resistance Level $15.29 $1.25
Average True Range (ATR) 0.58 0.05
MACD 0.10 -0.01
Stochastic Oscillator 31.82 0.14

Price Performance

Historical Comparison
TCX
ENLV

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. The company generates key revenue from Canada and USA.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: